The Enterprise Value as of November 2025 (TTM) for F-star Therapeutics, Inc. (FSTX) is 91.20M

According to F-star Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 91.20M. This represents a change of 51.21% compared to the average of 60.31M of the last 4 quarters.

F-star Therapeutics, Inc. (FSTX) Historical Enterprise Value (quarterly & annually)

How has FSTX Enterprise Value performed in the past?

The mean historical Enterprise Value of F-star Therapeutics, Inc. over the last ten years is 54.91M. The current 91.20M Enterprise Value has changed 16.51% with respect to the historical average. Over the past ten years (40 quarters), FSTX's Enterprise Value was at its highest in in the June 2019 quarter at 110.08M. The Enterprise Value was at its lowest in in the December 2019 quarter at -25485000.00.

F-star Therapeutics, Inc. (FSTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of F-star Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

F-star Therapeutics, Inc. (FSTX) Average Enterprise Value

How has FSTX Enterprise Value performed in the past?

The current Enterprise Value of F-star Therapeutics, Inc. (FSTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

F-star Therapeutics, Inc. (FSTX) Enterprise Value vs. Peers

How is FSTX’s Enterprise Value compared to its peers?

F-star Therapeutics, Inc.’s Enterprise Value is greater than Theseus Pharmaceuticals, Inc. (90.87M), greater than Selecta Biosciences, Inc. (-11774246.00), less than eXoZymes, Inc. (121.71M), greater than Pardes Biosciences, Inc. (75.90M), greater than aTyr Pharma, Inc. (87.32M), greater than Vaccitech plc (-33263316.00), greater than NGM Biopharmaceuticals, Inc. (69.72M), less than Sesen Bio, Inc. (127.66M), less than Paratek Pharmaceuticals, Inc. (351.99M), less than Decibel Therapeutics, Inc. (102.82M),

Build a custom stock screener for F-star Therapeutics, Inc. (FSTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like F-star Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

F-star Therapeutics, Inc. (FSTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like F-star Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.